Biden picks new NCI leader; American Cancer Society’s VC arm partners with Third Rock

The Biden administration has picked a renowned surgical oncologist as the next director of the National Cancer Institute. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by        The deadline is fast approaching to submit a nomination for STAT Wunderkinds, our annual program that celebrates early-career researchers. Nominate your candidate by July 29. STAT+: Biden picks renowned cancer surgeon Monica Bertagnolli as NCI chief By Lev Facher Dana-Farber Cancer Institute The Biden administration has selected Monica Bertagnolli, a surgical oncologist, as the next director of the National Cancer Institute. Read More STAT+: American Cancer Society's VC arm partners with Third Rock on oncology companies By Allison DeAngelis Adobe BrightEdge will be invited to participate in the Series A rounds for all of the oncology companies that Third Rock backs. Read More Collateral damage of the Fed's interest rate hikes: People who put medical bills on credit cards By Bob Herman Adobe Under new federal monetary policy, patients who put their medical bills on credit cards will likely be saddled with higher interest rates. Read More Sponsor content by The University of Texas MD Anderson Cancer Center MD Anderson proud to be #1 in the nation for cancer care MD Anderson Cancer Center is proud to be named number one in the nation for cancer care in U.S. News & World Report's Best Hospitals rankings and has consistently ranked as a top cancer hospital for 33 years. As the undisputed leader in cancer, MD Anderson offers patients exceptional, compassionate care, a greater depth of expertise and more groundbreaking clinical trials. Learn more at MDAnderson.org. Opinion: 6 ways to bolster FDA's guidance for diversifying participation in clinical trials By Nicholas Kenny and Keri McDonough and Stephen Keith Adobe The FDA's latest draft guidance on diversity among clinical trial participants is a good start. Here are ways to improve it. Read More Tuesday, July 26, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser